Carregant...
ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?
Cancer is the second leading cause of death worldwide. Today, the critical role of the immune system in tumor control is undisputed. Checkpoint antibody immunotherapy augments existing antitumor T cell activity with durable clinical responses in many tumor entities. Despite the presence of tumor-ass...
Guardat en:
| Publicat a: | Vaccines (Basel) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8161309/ https://ncbi.nlm.nih.gov/pubmed/34069708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050527 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|